Navigation Links
Avanir Pharmaceuticals Announces Results for Phase II PRIME Study
Date:12/10/2013

ALISO VIEJO, Calif., Dec. 10, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

In the PRIME study, AVP-923 treated patients experienced levels of pain reduction commensurate with those observed in similar studies and the improvement in pain scores from baseline reached statistical significance; however, there was no difference between the treatment arms and placebo.  Avanir believes that a higher than expected placebo response negatively impacted the study results.  AVP-923 was generally safe and well tolerated.

Avanir plans to review the detailed data from the PRIME study in conjunction with previously generated data in diabetic peripheral neuropathic pain to determine next steps for the development of AVP-923 in neuropathic pain.

About the PRIME Study
The objectives of the PRIME (Pain Research In Multiple sclErosis) study were to evaluate the safety, tolerability, and efficacy of AVP-923 for the treatment of central neuropathic pain in patients with multiple sclerosis. The trial was a multicenter, randomized, double-blind, placebo-controlled, 4-arm parallel group study that enrolled 209 patients. Eligible patients received one of three dose levels of AVP-923 containing either 45mg DM/10 mg Q, 30mg DM/10mg Q, 20mg DM/10mg Q or placebo, daily for 12 weeks. The primary efficacy endpoint was measured based on the Numeric Pain Rating Scale (PRS) as recorded in patient diaries. Primary analysis of this endpoint correlated pain
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares
2. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information
3. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
4. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
5. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
6. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
7. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
8. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
9. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
10. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
11. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)...  UBM Medica US announces that Cancer ... presents exclusive slide shows dealing with communication in the ... care. Cancer Network, the online ... blogs, and podcasts about the latest clinical findings. Among ... , End-of-life care is challenging for even the ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek Pharmaceuticals, ... it has initiated the development of its lead molecule, ... that it has selected Quotient Clinical, The Translational Pharmaceutics ... (UK) to run its early development programs. ... Application (CTA) by the end of the third quarter ...
(Date:7/31/2014)... Mass. , July 31, 2014 /PRNewswire/ ... funding changes brought about by the Affordable ... reimbursement and prescribing of pharmaceutical therapies. The ... cover beneficiaries through new regulations and expanded ... occurring in the health exchanges—state-based marketplaces set ...
Breaking Medicine Technology:Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4
... N.J. and LACHEN, Switzerland, Sept. 26, 2011 ... largest human protein products manufacturers in the world, has ... efficacy and safety of wilate® (von Willebrand ... post-operative bleeding in pediatric and adult patients with Type ...
... Accuray Incorporated (Nasdaq: ARAY ), the premier ... to present at the JMP Securities Healthcare Conference in New ... a.m. PDT. A live webcast of the presentation ... the Company,s website at http://www.accuray.com . The webcast replay ...
Cached Medicine Technology:Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 2Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 3
(Date:7/31/2014)... Joseph M. Lee, M.D., M.S., R.P.V.I, has ... leading provider of quality cardiovascular and internal medicine services ... Lee is a board certified cardiologist with a focus ... to his position at CDHV, Dr. Lee is an ... University Medical Center. Dr. Lee is board certified in ...
(Date:7/31/2014)... Setting goals for a fitness program is very ... to weight loss. Fitness on the Go has been helping ... has worked with 6000 customers on an individual basis throughout ... to monitor why customers start exercising with a personal ... to their program, whether or not they have a goal ...
(Date:7/31/2014)... Insight Accelerator Labs member PhysIQ (formerly known as ... for $4.6 million to fund the continued development of ... The company joined Insight Accelerator Labs in 2012 to ... of Insight development teams. , “PhysIQ’s recent ... says Steve McPhilliamy, Executive Director of Insight Accelerator Labs. ...
(Date:7/31/2014)... Millions of people avoid going to ... experiences as a child and some simply fear the ... a highly experienced NJ cosmetic dentist, Dr. Richard Champagne ... dental procedure. To help these patients receive the ... Smiles offer several sedation dentistry techniques. , Sedation dentistry ...
(Date:7/31/2014)... 31, 2014 Bedford Commons OB-GYN ... Innerspire: Brand ReEnergizers to do what Christina ... we connect with the community all while still offering ... practice, which caters to women’s health needs for every ... total women focused care ( Gynecology ), worked diligently ...
Breaking Medicine News(10 mins):Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:Fitness on the Go's Rewards Program Helps Clients Reach Their Goals 2Health News:Insight Accelerator Labs Advances Member Toward Commercialization 2Health News:Insight Accelerator Labs Advances Member Toward Commercialization 3Health News:Champagne Smiles is Thrilled to Now Offer Sedation Dentistry to their Patients 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 2Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 3Health News:Doctor Videos & Women’s Stories Jumpstart Local OB-GYN Practice 4
... California, San Francisco has received a $7.5 million grant ... the shortage of healthcare workers in Tanzania. The two-year ... Health Sciences and the Muhimbili University of Health Allied ... strategies to enable MUHAS and other African institutions to ...
... Parents of Children with DisabilitiesNEWTON, Mass., Jan. 6 ... of disabled children, today announced the launch of ... of children with disabilities, the Center hosts a ... families. ChildRC ( www.ChildRC.com ) offers informative content ...
... ACQUIRES HEMATOLOGY BUSINESS ASSETS FROM BIOCODE HYCELWAYNE, Pa., Jan. ... Market: ESMC) announced that on December 31, 2008 pursuant ... announced acquisition of the hematology business of Biocode Hycel, ... of in vitro diagnostic products. The acquired hematology business ...
... be biologically driven, researchers say , , TUESDAY, Jan. 6 ... physical or psychological abuse are more likely to develop ... , The study also states that the increased risk ... biology. The reason: There appears to be a connection ...
... conducted by the Society of Corporate Compliance and Ethics ... that the declining economy may be increasing the risk ... addition, this increased risk is occurring at a time ... at best hold steady, if not decline.The survey, based ...
... Depend on Plasma DonationANNAPOLIS, Md., Jan. 6 Kawasaki disease ... the ages of two and five and is a ... the United States according to the American Heart Association ... (IVIG), a plasma-derived therapy that replaces vital missing antibodies ...
Cached Medicine News:Health News:UCSF-Tanzania get $7.5M from Gates Foundation for partnership to train African health workers 2Health News:ChildRC.com Launches The Child Resource Center 2Health News:Escalon(R) Medical Corp. Completes Bolt-On Acquisition, Enhances Market Position in France and Expands Product Offering 2Health News:Escalon(R) Medical Corp. Completes Bolt-On Acquisition, Enhances Market Position in France and Expands Product Offering 3Health News:Childhood Trauma Tied to Chronic Fatigue Syndrome 2Health News:Childhood Trauma Tied to Chronic Fatigue Syndrome 3Health News:Legal and Ethical Violations Risks Seen Rising, But Not Resources to Control the Risk 2Health News:Legal and Ethical Violations Risks Seen Rising, But Not Resources to Control the Risk 3Health News:Kawasaki Disease Treated with Plasma-Derived Therapy 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: